Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers.

Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers. Clin Pharmacol Drug Dev. 2021 10; 10(10):1198-1208.

View in: PubMed

subject areas

Adult
Capsules
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Drug Compounding
Female
Food-Drug Interactions
Healthy Volunteers
Humans
Liver
Male
Non-alcoholic Fatty Liver Disease
Receptors, Cytoplasmic and Nuclear
Tablets

authors with profiles

Michael Charlton